Latest filing published 19 Aug 2026 for 에이프릴바이오.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
한재규: trading record in brief
한재규 is a declared insider of 에이프릴바이오, with filings sourced from DART (FSS). Over a trading history stretching from 15 July 2024 to 19 August 2026, the count stands at 3 filings.
In open-market terms, that means 2 purchases on one side and 1 sale on the other. The totals do not cover 3 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2026 alone, the filings show 1 purchase and 1 sale.
On 19 August 2026 came the latest disclosure, an open-market purchase in 에이프릴바이오. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Companies and markets linked to 한재규
Open company profiles for insider transactions, fundamentals and analyst consensus when available.